Skip to: Content
Skip to: Site Navigation
Skip to: Search

September 7, 2008 7:50:43 AM CDT

Learn about Newser Points »

« Back to the grid | Next story »

Tamiflu Will Carry Stronger Warning Labels

Posted Nov 28, 07 4:51 PM CST in Science & Health,  Business 

(Newser) – The maker of flu drug Tamiflu said today it will accept recommendations by a government panel that it revise printed warnings about the medication's side effects. Labels already warn of possible psychiatric reactions, but the panel recommended noting that some people have died, the AP reports. Drugmaker Roche says flu alone can trigger problems such as delirium and wants the labels to make that clear as well.

The FDA panel recommended that Roche add "cautionary language" after a spate of reports, mostly from Japan. The agency issued similar recommendations on Relenza, a flu drug produced by GlaxoSmithKline. Roche says its own research links psychiatric episodes to flu and not its drug. "Data increasingly points to the role of influenza in these events," a Roche rep says.

Sources Associated Press, Bloomberg

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Puerto Rican Drug Plants Shipped Tainted Pills: FDA

    Feb 6, 08 1:38 PM CST
    Puerto Rican Drug Plants Shipped Tainted Pills: FDA The Caribbean island that produces 13 of the 20 best-selling drugs in the US has sold tainted pills and is struggling with quality control at its pharmaceutical plants, AP reports.  FDA inspections of 13 Puerto Rican plants between 2003 and 2007 revealed problems such as machinery pins left in drug bottles and foreign material embedded in tablets. More »

  • Beefed-Up R&D Slows Drug Approval

    Jan 8, 08 5:45 PM CST
    Beefed-Up R&D Slows Drug Approval The FDA approved only 19 new drugs in 2007, the lowest total in 24 years. Bloomberg takes a look at the reasons. Some drug companies accuse the FDA of setting the bar higher for drug approvals, a charge the agency denies. Many, however, say the issue lies with big pharma devoting more attention to developing existing products than to creating new drugs. More »

  • FDA May Add Warnings to Flu Meds

    Nov 23, 07 4:12 PM CST
    FDA May Add Warnings to Flu Meds The FDA may change the labels of flu medications Tamiflu and Relenza to warn of serious side effects such as hallucinations, the Wall Street Journal reports. More than 700 so-called neuropsychiatric events—for example, children trying to "flee" by jumping through windows—and 16 deaths may be related to the drugs. Most reports come from Japan, where the drugs are most popular. More »

  • Diabetes Drug Given Strictest Warning Label

    Nov 14, 07 3:20 PM CST
    Diabetes Drug Given Strictest Warning Label The FDA has applied its harshest warning to the diabetes drug Avandia, declaring the product potentially increases risk of heart attacks. Now marked with a “black box” warning, GlaxoSmithKline’s drug will stay on the market pending a continuing “safety assessment,” the Wall Street Journal reports; FDA officials say the agency remains split on the wisdom of pulling the drug immediately. More »

  • FDA Panel Votes to Keep Avandia on Shelves

    Jul 30, 07 5:38 PM CDT
    FDA Panel Votes to Keep Avandia on Shelves An FDA panel said today that GlaxoSmithKline's diabetes drug Avandia should remain in drugstores, despite earlier evidence the pill ups heart failure risks. Glaxo has defended its drug, countering that the risks associated with the popular Avandia are the same as those of other diabetes drugs. More »

An employee of the pharmaceutical combination Roche in Kaiseraugst, Switzerland, supervises the production of the pharmaceutical "Tamiflu", pictured on Sept. 22, 2006.   (Associated Press)
An undated company photo provided by Swiss pharmaceutical concern Roche Products shows a worker supervising the package of the Tamiflu, the drug that combats the effects of bird flu in humans.   (Associated Press)
A box of Tamiflu is shown in this Feb. 9, 2007 file photo in Shanghai, China.   (Associated Press)
A warehouse operator removes samples of Tamiflu drugs to be photographed at a manufacturer's warehouse Friday, March 30, 2007 in Singapore.   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 1)

Tags

FDA  • GlaxoSmithKline  • Tamiflu  • Relenza  • flu medications


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular


Other Business Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »